Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Mojgan Naghitorabi"'
Publikováno v:
Research in Pharmaceutical Sciences, Vol 16, Iss 3, Pp 278-285 (2021)
Background and purpose: Since DNA methyltransferase enzymes play a key role in DNA methylation, they can be used as a target to alter epigenetic changes and treat cancer. Recent studies have shown that olsalazine, through its potent inhibitory effect
Externí odkaz:
https://doaj.org/article/4d03b7a44d82409f814e73eadc39cb1d
Autor:
Mojgan Naghitorabi, Javad Mohammadi-Asl, Hamid Mir Mohammad Sadeghi, Mohammad Rabbani, Abbas Jafarian-Dehkordi, Shaghayegh Haghjooy Javanmard
Publikováno v:
Advanced Biomedical Research, Vol 5, Iss 1, Pp 91-91 (2016)
Background: E-cadherin (CDH1) plays an important role in cell–cell adhesion of epithelial tissues. Loss of E-cadherin expression can lead to loss of tissue integrity, metastasis, and cancer progression. Also loss of E-cadherin expression might be r
Externí odkaz:
https://doaj.org/article/b0b1ccc69f544786aaabb6cd239c70bb
Publikováno v:
Research in Pharmaceutical Sciences, Vol 16, Iss 3, Pp 278-285 (2021)
Research in Pharmaceutical Sciences
Research in Pharmaceutical Sciences
Background and purpose: Since DNA methyltransferase enzymes play a key role in DNA methylation, they can be used as a target to alter epigenetic changes and treat cancer. Recent studies have shown that olsalazine, through its potent inhibitory effect
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2de4dfde3f887f4fbd407ca9d91e5b69
http://www.rpsjournal.net/article.asp?issn=1735-5362
http://www.rpsjournal.net/article.asp?issn=1735-5362
Publikováno v:
Jundishapur Journal of Natural Pharmaceutical Products. 15
Background: A main epigenetic change in cancer is DNA methylation, which leads to the inactivation of tumor suppressor genes. Due to its reversible nature, many studies have focused on how to correct epigenetic imbalances via inhibiting DNA methyltra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9dbc66d581e34794996a5cddf22fec03
https://doi.org/10.5812/jjnpp.69428
https://doi.org/10.5812/jjnpp.69428
Autor:
Mojgan Naghitorabi
Publikováno v:
Jundishapur Journal of Natural Pharmaceutical Products. 13
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::affd8918d01c4fc96296d273450c9f24
https://doi.org/10.5812/jjnpp.69295
https://doi.org/10.5812/jjnpp.69295
Autor:
Mojgan, Naghitorabi, Hamid, Mir Mohammad Sadeghi, Javad, Mohammadi Asl, Mohammad, Rabbani, Abbas, Jafarian-Dehkordi
Publikováno v:
Iranian Journal of Pharmaceutical Research : IJPR
Promoter methylation is one of the main epigenetic mechanisms that leads to the inactivation of tumor suppressor genes during carcinogenesis. Due to the reversible nature of DNA methylation, many studies have been performed to correct theses epigenet
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c737281a4e9266d6d280f675a2e560fe
https://pubmed.ncbi.nlm.nih.gov/28979331
https://pubmed.ncbi.nlm.nih.gov/28979331
Autor:
Javad Mohammadi-Asl, Mojgan Naghitorabi, Mohammad Rabbani, Abbas Jafarian-Dehkordi, Shaghayegh Haghjooy Javanmard, Heydar Sadeghi
Publikováno v:
Advanced Biomedical Research, Vol 5, Iss 1, Pp 91-91 (2016)
Advanced Biomedical Research
Advanced Biomedical Research
Background: E-cadherin (CDH1) plays an important role in cell–cell adhesion of epithelial tissues. Loss of E-cadherin expression can lead to loss of tissue integrity, metastasis, and cancer progression. Also loss of E-cadherin expression might be r
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8fc1c1d925b67fd960fb8ac806e1a0c6
http://www.advbiores.net/article.asp?issn=2277-9175
http://www.advbiores.net/article.asp?issn=2277-9175
Publikováno v:
Scopus-Elsevier
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::13da4ca52f2657d634c822473a4e0b97
http://www.scopus.com/inward/record.url?eid=2-s2.0-85021366726&partnerID=MN8TOARS
http://www.scopus.com/inward/record.url?eid=2-s2.0-85021366726&partnerID=MN8TOARS
